Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Alerts
News
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars
10th Anniversary

Skip Nav Destination

Current Issue

Volume 12,

Issue 4

1 April 2024

View This Issue

About the Journal

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. Read More About the Journal

Editors-in-Chief

Robert D. Schreiber
Philip D. Greenberg

View Full Editorial Board

Impact Factor

10.1

SUBMIT TO JOURNAL

Featured Articles

Research Article

High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models

Émilie Degagné, et al.

Research Article

Neutrophils Mediate Protection Against Colitis and Carcinogenesis by Controlling Bacterial Invasion and IL22 Production by γδ T Cells

Silvia Carnevale, et al.

Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer

Hewitt Chang, et al.

Trending - Altmetric

The article titled, Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis, has an Alt Metric Attention Score of 11.5. Click to see more of this article's metrics.

Read the article titled, Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis

Last mentioned on Tuesday April 16 2024

The article titled, Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors, has an Alt Metric Attention Score of 48.58. Click to see more of this article's metrics.

Read the article titled, Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors

Last mentioned on Thursday April 11 2024

The article titled, SIRT3 negatively regulates TFH cell differentiation in cancer., has an Alt Metric Attention Score of 1. Click to see more of this article's metrics.

Read the article titled, SIRT3 negatively regulates TFH cell differentiation in cancer.

Last mentioned on Wednesday April 17 2024

The article titled, The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity, has an Alt Metric Attention Score of 2.35. Click to see more of this article's metrics.

Read the article titled, The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity

Last mentioned on Thursday April 11 2024

The article titled, Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma., has an Alt Metric Attention Score of 3.25. Click to see more of this article's metrics.

Read the article titled, Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma.

Last mentioned on Thursday April 11 2024

Latest
Most Read
Most Cited

Small Extracellular Vesicle piR-hsa-30937 Derived from Pancreatic Neuroendocrine Neoplasms Upregulates CD276 in Macrophages to Promote Immune Evasion

SIRT3 negatively regulates TFH cell differentiation in cancer

Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes

Orchestrated codelivery of peptide antigen and adjuvant to antigen-presenting cells by using an engineered chimeric peptide enhances antitumor T-cell immunity

The X live feed is not currently active.

Keep up to date with Cancer Immunology Research

Follow @CIR_AACR

Issues
Online First
News

Twitter

Online ISSN 2326-6074
Print ISSN 2326-6066

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Information for Institutions/Librarians
RSS Feeds
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept